Cargando…

SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites

Detalles Bibliográficos
Autores principales: Gao, Yuan, Wei, Lai, Zhang, Dorothy Da, Chen, Yu, Hou, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666362/
https://www.ncbi.nlm.nih.gov/pubmed/34966642
http://dx.doi.org/10.14218/JCTH.2021.00418
_version_ 1784614192217587712
author Gao, Yuan
Wei, Lai
Zhang, Dorothy Da
Chen, Yu
Hou, Bing
author_facet Gao, Yuan
Wei, Lai
Zhang, Dorothy Da
Chen, Yu
Hou, Bing
author_sort Gao, Yuan
collection PubMed
description
format Online
Article
Text
id pubmed-8666362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-86663622021-12-28 SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites Gao, Yuan Wei, Lai Zhang, Dorothy Da Chen, Yu Hou, Bing J Clin Transl Hepatol Letter to the Editor XIA & HE Publishing Inc. 2021-12-28 2021-11-26 /pmc/articles/PMC8666362/ /pubmed/34966642 http://dx.doi.org/10.14218/JCTH.2021.00418 Text en © 2021 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Gao, Yuan
Wei, Lai
Zhang, Dorothy Da
Chen, Yu
Hou, Bing
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
title SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
title_full SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
title_fullStr SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
title_full_unstemmed SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
title_short SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
title_sort sglt2 inhibitors: a new dawn for recurrent/refractory cirrhotic ascites
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666362/
https://www.ncbi.nlm.nih.gov/pubmed/34966642
http://dx.doi.org/10.14218/JCTH.2021.00418
work_keys_str_mv AT gaoyuan sglt2inhibitorsanewdawnforrecurrentrefractorycirrhoticascites
AT weilai sglt2inhibitorsanewdawnforrecurrentrefractorycirrhoticascites
AT zhangdorothyda sglt2inhibitorsanewdawnforrecurrentrefractorycirrhoticascites
AT chenyu sglt2inhibitorsanewdawnforrecurrentrefractorycirrhoticascites
AT houbing sglt2inhibitorsanewdawnforrecurrentrefractorycirrhoticascites